Cancer Research Meeting Calendar Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, H.
Right arrow Articles by Tsang, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, H.
Right arrow Articles by Tsang, B. K.
[Cancer Research 60, 5659-5666, October 15, 2000]
© 2000 American Association for Cancer Research

Biochemistry and Biophysics

Down-Regulation of X-linked Inhibitor of Apoptosis Protein Induces Apoptosis in Chemoresistant Human Ovarian Cancer Cells1

Hiromasa Sasaki2, YingLun Sheng2, Fumikazu Kotsuji and Benjamin K. Tsang3

Reproductive Biology Unit and Division of Gynaecologic Oncology, Departments of Obstetrics and Gynaecology and Cellular and Molecular Medicine, University of Ottawa, and Loeb Health Research Institute, The Ottawa Hospital, Civic Campus, Ottawa, Ontario, Canada K1Y 4E9 [H. S., Y. S., B. K. T]; and Department of Obstetrics and Gynaecology, Fukui Medical University, Fukui, Japan 910-1193 [F. K.]

Cisplatin-centeredchemotherapy is a key treatment for ovarian cancer, but resistance to chemotherapeutic agents remains a major cause of treatment failure. Multiple factors are known to contribute to the development of this chemoresistance. Although it has been demonstrated that X-linked inhibitor of apoptosis protein (Xiap) prevents apoptosis by inhibiting effector caspases, if and how it is important in chemoresistance in ovarian cancer has not been studied. The effects of Xiap down-regulation and/or restoration of wild type p53 by recombinant adenovirus infection were examined on four ovarian epithelial cancer cell lines [C13*, A2780-s (wild type p53), A2780-cp (mutant p53), and SKOV3 (null p53)]. Apoptosis and protein expression (e.g., Xiap, caspase-3, p53, MDM2, and p21waf1) were assessed by Hoechst 33258 stain and Western blot, respectively. We demonstrated that Xiap down-regulation following adenoviral antisense expression induces apoptosis in the wild-type p53 cells, but not in the mutated or null cells. Xiap down-regulation resulted in caspase-3 activation, caspase-mediated MDM2 processing, and p53 accumulation. Restoration of wild type p53 in the p53-mutated or -null cells significantly enhanced the proapoptotic effect of Xiap antisense expression. Down-regulation of Xiap induced apoptosis in chemoresistant ovarian cancer cells, a process dependent on p53 status.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
J.-P. Guo, S.-K. Shu, L. He, Y.-C. Lee, P. A. Kruk, S. Grenman, S. V. Nicosia, G. Mor, M. J. Schell, D. Coppola, et al.
Deregulation of IKBKE Is Associated with Tumor Progression, Poor Prognosis, and Cisplatin Resistance in Ovarian Cancer
Am. J. Pathol., July 1, 2009; 175(1): 324 - 333.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Wang, W. Zhang, Y. Zhang, Y. Chen, B. Zou, B. Jiang, R. Pang, Q. Gu, L. Qiao, H. Lan, et al.
c-Jun N-terminal kinase (JNK1) upregulates XIAP-associated factor 1 (XAF1) through interferon regulatory factor 1 (IRF-1) in gastrointestinal cancer
Carcinogenesis, February 1, 2009; 30(2): 222 - 229.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
Q. Zhong, Y.-J. Wen, H.-S. Yang, H. Luo, A.-F. Fu, F. Yang, L.-J. Chen, X. Chen, X.-R. Qi, H.-G. Lin, et al.
Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice
Ann. Onc., September 1, 2008; 19(9): 1584 - 1591.
[Abstract] [Full Text] [PDF]

Home page
 GENES CELLSHome page
T. Hashimoto, L. Yamauchi, T. Hunter, U. Kikkawa, and S. Kamada
Possible involvement of caspase-7 in cell cycle progression at mitosis.
Genes Cells, June 1, 2008; 13(6): 609 - 621.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. P. Zehntner, L. Bourbonniere, C. S. Moore, S. J. Morris, D. Methot, M. St. Jean, E. Lacasse, A. L. O. Hebb, G. S. Robertson, J. Durkin, et al.
X-linked Inhibitor of Apoptosis Regulates T Cell Effector Function
J. Immunol., December 1, 2007; 179(11): 7553 - 7560.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Vucic and W. J. Fairbrother
The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer
Clin. Cancer Res., October 15, 2007; 13(20): 5995 - 6000.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
E. Weisberg, A. L. Kung, R. D. Wright, D. Moreno, L. Catley, A. Ray, L. Zawel, M. Tran, J. Cools, G. Gilliland, et al.
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells
Mol. Cancer Ther., July 1, 2007; 6(7): 1951 - 1961.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. Chowdhury, W. Xu, J. K. Stiles, A. Zeleznik, X. Yao, R. Matthews, K. Thomas, and W. E. Thompson
Apoptosis of Rat Granulosa Cells after Staurosporine and Serum Withdrawal Is Suppressed by Adenovirus-Directed Overexpression of Prohibitin
Endocrinology, January 1, 2007; 148(1): 206 - 217.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T.-J. Lee, E. M. Jung, J. T. Lee, S. Kim, J.-W. Park, K. S. Choi, and T. K. Kwon
Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites.
Mol. Cancer Ther., November 1, 2006; 5(11): 2737 - 2746.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
H. Wang, J.-Y. Jiang, C. Zhu, C. Peng, and B. K. Tsang
Role and Regulation of Nodal/Activin Receptor-Like Kinase 7 Signaling Pathway in the Control of Ovarian Follicular Atresia
Mol. Endocrinol., October 1, 2006; 20(10): 2469 - 2482.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Yang, M. Fraser, U. M. Moll, A. Basak, and B. K. Tsang
Akt-Mediated Cisplatin Resistance in Ovarian Cancer: Modulation of p53 Action on Caspase-Dependent Mitochondrial Death Pathway.
Cancer Res., March 15, 2006; 66(6): 3126 - 3136.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Lane, M. Cote, R. Grondin, M.-C. Couture, and A. Piche
Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3.
Mol. Cancer Ther., March 1, 2006; 5(3): 509 - 521.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
A. B. Alvero, W. Chen, A. C. Sartorelli, P. Schwartz, T. Rutherford, and G. Mor
Triapine (3-aninopyridine-2-carboxaldehyde thiosemicarbazone) Induces Apoptosis in Ovarian Cancer Cells
Reproductive Sciences, February 1, 2006; 13(2): 145 - 152.
[Abstract] [PDF]

Home page
 BloodHome page
A. P. Kater, F. Dicker, M. Mangiola, K. Welsh, R. Houghten, J. Ostresh, A. Nefzi, J. C. Reed, C. Pinilla, and T. J. Kipps
Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis
Blood, September 1, 2005; 106(5): 1742 - 1748.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. C. Reed and M. Pellecchia
Apoptosis-based therapies for hematologic malignancies
Blood, July 15, 2005; 106(2): 408 - 418.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
U. Fischer and K. Schulze-Osthoff
New Approaches and Therapeutics Targeting Apoptosis in Disease
Pharmacol. Rev., June 1, 2005; 57(2): 187 - 215.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Z. Carter, M. Gronda, Z. Wang, K. Welsh, C. Pinilla, M. Andreeff, W. D. Schober, A. Nefzi, G. R. Pond, I. A. Mawji, et al.
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells
Blood, May 15, 2005; 105(10): 4043 - 4050.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
Y. Mizutani, H. Nakanishi, K. Yamamoto, Y. N. Li, H. Matsubara, K. Mikami, K. Okihara, A. Kawauchi, B. Bonavida, and T. Miki
Downregulation of Smac/DIABLO Expression in Renal Cell Carcinoma and Its Prognostic Significance
J. Clin. Oncol., January 20, 2005; 23(3): 448 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. A. Sinicrope, R. C. Penington, and X. M. Tang
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis Is Inhibited by Bcl-2 but Restored by the Small Molecule Bcl-2 Inhibitor, HA 14-1, in Human Colon Cancer Cells
Clin. Cancer Res., December 15, 2004; 10(24): 8284 - 8292.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Mabuchi, M. Ohmichi, Y. Nishio, T. Hayasaka, A. Kimura, T. Ohta, J. Kawagoe, K. Takahashi, N. Yada-Hashimoto, H. Seino-Noda, et al.
Inhibition of Inhibitor of Nuclear Factor-{kappa}B Phosphorylation Increases the Efficacy of Paclitaxel in in Vitro and in Vivo Ovarian Cancer Models
Clin. Cancer Res., November 15, 2004; 10(22): 7645 - 7654.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Wang, M. Cuddy, T. Samuel, K. Welsh, A. Schimmer, F. Hanaii, R. Houghten, C. Pinilla, and J. C. Reed
Cellular, Biochemical, and Genetic Analysis of Mechanism of Small Molecule IAP Inhibitors
J. Biol. Chem., November 12, 2004; 279(46): 48168 - 48176.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Xu, Y. Zhong, S. Munir, B. B. Yang, B. K. Tsang, and C. Peng
Nodal Induces Apoptosis and Inhibits Proliferation in Human Epithelial Ovarian Cancer Cells via Activin Receptor-Like Kinase 7
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5523 - 5534.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. D. Schimmer
Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice
Cancer Res., October 15, 2004; 64(20): 7183 - 7190.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
N. PURI, M. S. ELLER, H. R. BYERS, S. DYKSTRA, J. KUBERA, and B. A. GILCHREST
Telomere-based DNA damage responses: a new approach to melanoma
FASEB J, September 1, 2004; 18(12): 1373 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Mabuchi, M. Ohmichi, Y. Nishio, T. Hayasaka, A. Kimura, T. Ohta, M. Saito, J. Kawagoe, K. Takahashi, N. Yada-Hashimoto, et al.
Inhibition of NF{kappa}B Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
J. Biol. Chem., May 28, 2004; 279(22): 23477 - 23485.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-Q. Li, A. I. Robles, C. L. Hanigan, L. J. Hofseth, L. J. Trudel, C. C. Harris, and G. N. Wogan
Apoptotic Signaling Pathways Induced by Nitric Oxide in Human Lymphoblastoid Cells Expressing Wild-Type or Mutant p53
Cancer Res., May 1, 2004; 64(9): 3022 - 3029.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. C. Dan, M. Sun, S. Kaneko, R. I. Feldman, S. V. Nicosia, H.-G. Wang, B. K. Tsang, and J. Q. Cheng
Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)
J. Biol. Chem., February 13, 2004; 279(7): 5405 - 5412.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Z. Carter, S. M. Kornblau, T. Tsao, R.-Y. Wang, W. D. Schober, M. Milella, H.-G. Sung, J. C. Reed, and M. Andreeff
Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis
Blood, December 1, 2003; 102(12): 4179 - 4186.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D.-S. Byun, K. Cho, B.-K. Ryu, M.-G. Lee, M.-J. Kang, H.-R. Kim, and S.-G. Chi
Hypermethylation of XIAP-associated Factor 1, a Putative Tumor Suppressor Gene from the 17p13.2 Locus, in Human Gastric Adenocarcinomas
Cancer Res., November 1, 2003; 63(21): 7068 - 7075.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Fraser, B. M. Leung, X. Yan, H. C. Dan, J. Q. Cheng, and B. K. Tsang
p53 Is a Determinant of X-Linked Inhibitor of Apoptosis Protein/Akt-Mediated Chemoresistance in Human Ovarian Cancer Cells
Cancer Res., November 1, 2003; 63(21): 7081 - 7088.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Yang, Z. Cao, H. Yan, and W. C. Wood
Coexistence of High Levels of Apoptotic Signaling and Inhibitor of Apoptosis Proteins in Human Tumor Cells: Implication for Cancer Specific Therapy
Cancer Res., October 15, 2003; 63(20): 6815 - 6824.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Krajewska, S. Krajewski, S. Banares, X. Huang, B. Turner, L. Bubendorf, O.-P. Kallioniemi, A. Shabaik, A. Vitiello, D. Peehl, et al.
Elevated Expression of Inhibitor of Apoptosis Proteins in Prostate Cancer
Clin. Cancer Res., October 15, 2003; 9(13): 4914 - 4925.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. A. Shabbits, Y. Hu, and L. D. Mayer
Tumor Chemosensitization Strategies Based on Apoptosis Manipulations
Mol. Cancer Ther., August 1, 2003; 2(8): 805 - 813.
[Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Hu, M. Bally, W. H. Dragowska, and L. Mayer
Inhibition of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase Enhances Chemotherapeutic Effects on H460 Human Non-Small Cell Lung Cancer Cells through Activation of Apoptosis
Mol. Cancer Ther., July 1, 2003; 2(7): 641 - 649.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Hu, G. Cherton-Horvat, V. Dragowska, S. Baird, R. G. Korneluk, J. P. Durkin, L. D. Mayer, and E. C. LaCasse
Antisense Oligonucleotides Targeting XIAP Induce Apoptosis and Enhance Chemotherapeutic Activity against Human Lung Cancer Cells in Vitro and in Vivo
Clin. Cancer Res., July 1, 2003; 9(7): 2826 - 2836.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
X. Hong, L. Lei, and R. Glas
Tumors Acquire Inhibitor of Apoptosis Protein (IAP)-mediated Apoptosis Resistance through Altered Specificity of Cytosolic Proteolysis
J. Exp. Med., June 16, 2003; 197(12): 1731 - 1743.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
Y. Wang, P. U. Rippstein, and B. K. Tsang
Role and Gonadotrophic Regulation of X-Linked Inhibitor of Apoptosis Protein Expression During Rat Ovarian Follicular Development In Vitro
Biol Reprod, February 1, 2003; 68(2): 610 - 619.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Wittmann, P. Bali, S. Donapaty, R. Nimmanapalli, F. Guo, H. Yamaguchi, M. Huang, R. Jove, H. G. Wang, and K. Bhalla
Flavopiridol Down-Regulates Antiapoptotic Proteins and Sensitizes Human Breast Cancer Cells to Epothilone B-induced Apoptosis
Cancer Res., January 1, 2003; 63(1): 93 - 99.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C.-P. Ng and B. Bonavida
X-linked Inhibitor of Apoptosis (XIAP) Blocks Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis of Prostate Cancer Cells in the Presence of Mitochondrial Activation: Sensitization by Overexpression of Second Mitochondria-derived Activator of Caspase/Direct IAP-binding Protein with Low pI (Smac/DIABLO)
Mol. Cancer Ther., October 1, 2002; 1(12): 1051 - 1058.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C.-Q. Li, L. J. Trudel, and G. N. Wogan
Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53
PNAS, August 6, 2002; 99(16): 10364 - 10369.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K.-C. Huang, P. H. Rao, C. C. Lau, E. Heard, S.-K. Ng, C. Brown, S. C. Mok, R. S. Berkowitz, and S.-W. Ng
Relationship of XIST Expression and Responses of Ovarian Cancer to Chemotherapy
Mol. Cancer Ther., August 1, 2002; 1(10): 769 - 776.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. G. Ferreira, M. Epping, F. A. E. Kruyt, and G. Giaccone
Apoptosis: Target of Cancer Therapy
Clin. Cancer Res., July 1, 2002; 8(7): 2024 - 2034.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Guo, R. Nimmanapalli, S. Paranawithana, S. Wittman, D. Griffin, P. Bali, E. O'Bryan, C. Fumero, H. G. Wang, and K. Bhalla
Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis
Blood, May 1, 2002; 99(9): 3419 - 3426.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Alas, C.-P. Ng, and B. Bonavida
Rituximab Modifies the Cisplatin-mitochondrial Signaling Pathway, Resulting in Apoptosis in Cisplatin-resistant Non-Hodgkin's Lymphoma
Clin. Cancer Res., March 1, 2002; 8(3): 836 - 845.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
Y. Deng, Y. Lin, and X. Wu
TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO
Genes & Dev., January 1, 2002; 16(1): 33 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. Gruslin, Q. Qiu, and B. K. Tsang
Influence of Maternal Smoking on Trophoblast Apoptosis Throughout Development: Possible Involvement of Xiap Regulation
Biol Reprod, October 1, 2001; 65(4): 1164 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. K. Yiu, W. Y. Chan, S.-W. Ng, P. S. Chan, K. K. Cheung, R. S. Berkowitz, and S. C. Mok
SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer Cells
Am. J. Pathol., August 1, 2001; 159(2): 609 - 622.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
C. G. Ferreira, P. van der Valk, S. W. Span, I. Ludwig, E. F. Smit, F. A. E. Kruyt, H. M. Pinedo, H. van Tinteren, and G. Giaccone
Expression of X-linked Inhibitor of Apoptosis as a Novel Prognostic Marker in Radically Resected Non-Small Cell Lung Cancer Patients
Clin. Cancer Res., August 1, 2001; 7(8): 2468 - 2474.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Asselin, G. B. Mills, and B. K. Tsang
XIAP Regulates Akt Activity and Caspase-3-dependent Cleavage during Cisplatin-induced Apoptosis in Human Ovarian Epithelial Cancer Cells
Cancer Res., March 1, 2001; 61(5): 1862 - 1868.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
C. W. Xiao, K. Ash, and B. K. Tsang
Nuclear Factor-{{kappa}}B-Mediated X-Linked Inhibitor of Apoptosis Protein Expression Prevents Rat Granulosa Cells from Tumor Necrosis Factor {{alpha}}-Induced Apoptosis
Endocrinology, February 1, 2001; 142(2): 557 - 563.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Li, Q. Feng, J.-M. Kim, D. Schneiderman, P. Liston, M. Li, B. Vanderhyden, W. Faught, M. F. K. Fung, M. Senterman, et al.
Human Ovarian Cancer and Cisplatin Resistance: Possible Role of Inhibitor of Apoptosis Proteins
Endocrinology, January 1, 2001; 142(1): 370 - 380.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.